vs
Calumet, Inc.（CLMT）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
瑞思迈的季度营收约是Calumet, Inc.的1.4倍（$1.4B vs $1.0B），瑞思迈净利率更高（27.6% vs -3.6%，领先31.2%），瑞思迈自由现金流更多（$311.2M vs $103.8M）
Calumet是总部位于美国的特种产品企业，专注于生产和分销高价值碳氢化合物与特种化学品，产品覆盖特种油、润滑剂、蜡制品及可再生燃料解决方案，服务北美及全球的工业、消费、交通等下游领域。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
CLMT vs RMD — 直观对比
营收规模更大
RMD
是对方的1.4倍
$1.0B
净利率更高
RMD
高出31.2%
-3.6%
自由现金流更多
RMD
多$207.4M
$103.8M
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.0B | $1.4B |
| 净利润 | $-37.3M | $392.6M |
| 毛利率 | -0.3% | 61.8% |
| 营业利润率 | -6.2% | 34.6% |
| 净利率 | -3.6% | 27.6% |
| 营收同比 | — | 11.0% |
| 净利润同比 | — | 13.9% |
| 每股收益（稀释后） | $-0.43 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLMTRMD
| Q4 25 | $1.0B | $1.4B | ||
| Q3 25 | $1.1B | $1.3B | ||
| Q2 25 | $1.0B | $1.3B | ||
| Q1 25 | $993.9M | $1.3B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | $1.1B | $1.2B | ||
| Q2 24 | $1.1B | $1.2B | ||
| Q1 24 | — | $1.2B |
净利润CLMTRMD
| Q4 25 | $-37.3M | $392.6M | ||
| Q3 25 | $313.4M | $348.5M | ||
| Q2 25 | $-147.9M | $379.7M | ||
| Q1 25 | $-162.0M | $365.0M | ||
| Q4 24 | — | $344.6M | ||
| Q3 24 | $-100.6M | $311.4M | ||
| Q2 24 | $-39.1M | $292.2M | ||
| Q1 24 | — | $300.5M |
毛利率CLMTRMD
| Q4 25 | -0.3% | 61.8% | ||
| Q3 25 | 34.7% | 61.5% | ||
| Q2 25 | -4.2% | 60.8% | ||
| Q1 25 | -8.2% | 59.3% | ||
| Q4 24 | — | 58.6% | ||
| Q3 24 | 0.4% | 58.6% | ||
| Q2 24 | 5.6% | 58.5% | ||
| Q1 24 | — | 57.9% |
营业利润率CLMTRMD
| Q4 25 | -6.2% | 34.6% | ||
| Q3 25 | 30.0% | 33.4% | ||
| Q2 25 | -9.8% | 33.7% | ||
| Q1 25 | -4.9% | 33.0% | ||
| Q4 24 | — | 32.5% | ||
| Q3 24 | -5.2% | 31.6% | ||
| Q2 24 | 0.5% | 31.2% | ||
| Q1 24 | — | 31.3% |
净利率CLMTRMD
| Q4 25 | -3.6% | 27.6% | ||
| Q3 25 | 29.1% | 26.1% | ||
| Q2 25 | -14.4% | 28.2% | ||
| Q1 25 | -16.3% | 28.3% | ||
| Q4 24 | — | 26.9% | ||
| Q3 24 | -9.1% | 25.4% | ||
| Q2 24 | -3.4% | 23.9% | ||
| Q1 24 | — | 25.1% |
每股收益（稀释后）CLMTRMD
| Q4 25 | $-0.43 | $2.68 | ||
| Q3 25 | $3.61 | $2.37 | ||
| Q2 25 | $-1.70 | $2.58 | ||
| Q1 25 | $-1.87 | $2.48 | ||
| Q4 24 | — | $2.34 | ||
| Q3 24 | $-1.18 | $2.11 | ||
| Q2 24 | $-0.48 | $1.97 | ||
| Q1 24 | — | $2.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $125.1M | $1.4B |
| 总债务越低越好 | $2.1B | $403.9M |
| 股东权益账面价值 | $-732.7M | $6.3B |
| 总资产 | $2.7B | $8.5B |
| 负债/权益比越低杠杆越低 | — | 0.06× |
8季度趋势，按日历期对齐
现金及短期投资CLMTRMD
| Q4 25 | $125.1M | $1.4B | ||
| Q3 25 | $94.6M | $1.4B | ||
| Q2 25 | $110.6M | $1.2B | ||
| Q1 25 | $123.4M | $932.7M | ||
| Q4 24 | — | $521.9M | ||
| Q3 24 | $34.6M | $426.4M | ||
| Q2 24 | $7.0M | $238.4M | ||
| Q1 24 | — | $237.9M |
总债务CLMTRMD
| Q4 25 | $2.1B | $403.9M | ||
| Q3 25 | $2.1B | $408.7M | ||
| Q2 25 | $2.1B | $658.4M | ||
| Q1 25 | $2.3B | $663.1M | ||
| Q4 24 | — | $662.9M | ||
| Q3 24 | $1.7B | $667.6M | ||
| Q2 24 | — | $697.3M | ||
| Q1 24 | — | $997.0M |
股东权益CLMTRMD
| Q4 25 | $-732.7M | $6.3B | ||
| Q3 25 | $-695.3M | $6.1B | ||
| Q2 25 | $-1.0B | $6.0B | ||
| Q1 25 | $-862.3M | $5.5B | ||
| Q4 24 | — | $5.3B | ||
| Q3 24 | $-672.2M | $5.2B | ||
| Q2 24 | $-566.4M | $4.9B | ||
| Q1 24 | — | $4.6B |
总资产CLMTRMD
| Q4 25 | $2.7B | $8.5B | ||
| Q3 25 | $2.7B | $8.3B | ||
| Q2 25 | $2.8B | $8.2B | ||
| Q1 25 | $2.8B | $7.6B | ||
| Q4 24 | — | $7.1B | ||
| Q3 24 | $2.6B | $7.2B | ||
| Q2 24 | $100 | $6.9B | ||
| Q1 24 | — | $6.8B |
负债/权益比CLMTRMD
| Q4 25 | — | 0.06× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.12× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.13× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | — | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $116.5M | $339.7M |
| 自由现金流经营现金流 - 资本支出 | $103.8M | $311.2M |
| 自由现金流率自由现金流/营收 | 10.0% | 21.9% |
| 资本支出强度资本支出/营收 | 1.2% | 2.0% |
| 现金转化率经营现金流/净利润 | — | 0.87× |
| 过去12个月自由现金流最近4个季度 | $56.6M | $1.8B |
8季度趋势，按日历期对齐
经营现金流CLMTRMD
| Q4 25 | $116.5M | $339.7M | ||
| Q3 25 | $23.5M | $457.3M | ||
| Q2 25 | $-1.8M | $538.8M | ||
| Q1 25 | $-29.3M | $578.7M | ||
| Q4 24 | — | $308.6M | ||
| Q3 24 | $-15.5M | $325.5M | ||
| Q2 24 | — | $440.1M | ||
| Q1 24 | — | $402.0M |
自由现金流CLMTRMD
| Q4 25 | $103.8M | $311.2M | ||
| Q3 25 | $15.1M | $414.4M | ||
| Q2 25 | $-15.4M | $508.2M | ||
| Q1 25 | $-46.9M | $557.9M | ||
| Q4 24 | — | $288.0M | ||
| Q3 24 | $-32.2M | $307.7M | ||
| Q2 24 | — | $415.2M | ||
| Q1 24 | — | $380.8M |
自由现金流率CLMTRMD
| Q4 25 | 10.0% | 21.9% | ||
| Q3 25 | 1.4% | 31.0% | ||
| Q2 25 | -1.5% | 37.7% | ||
| Q1 25 | -4.7% | 43.2% | ||
| Q4 24 | — | 22.5% | ||
| Q3 24 | -2.9% | 25.1% | ||
| Q2 24 | — | 33.9% | ||
| Q1 24 | — | 31.8% |
资本支出强度CLMTRMD
| Q4 25 | 1.2% | 2.0% | ||
| Q3 25 | 0.8% | 3.2% | ||
| Q2 25 | 1.3% | 2.3% | ||
| Q1 25 | 1.8% | 1.6% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | 1.5% | 1.5% | ||
| Q2 24 | 2.2% | 2.0% | ||
| Q1 24 | — | 1.8% |
现金转化率CLMTRMD
| Q4 25 | — | 0.87× | ||
| Q3 25 | 0.07× | 1.31× | ||
| Q2 25 | — | 1.42× | ||
| Q1 25 | — | 1.59× | ||
| Q4 24 | — | 0.90× | ||
| Q3 24 | — | 1.05× | ||
| Q2 24 | — | 1.51× | ||
| Q1 24 | — | 1.34× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLMT
| Specialty Products And Solutions | $675.9M | 65% |
| Montana Renewables | $294.2M | 28% |
| Performance Brands | $68.5M | 7% |
RMD
| Sleep And Breathing Health | $1.3B | 88% |
| Residential Care Software | $166.9M | 12% |
